Use of somatostatin receptor scintigraphy to image extrahepatic metastases of neuroendocrine tumors

被引:40
作者
Frilling, A [1 ]
Malago, M [1 ]
Martin, H [1 ]
Broelsch, CE [1 ]
机构
[1] Univ Hamburg Hosp, Dept Gen Surg, D-2000 Hamburg, Germany
关键词
D O I
10.1067/msy.1998.93919
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background. The presence of lymph node metastases significantly influences the modality of treatment in patients with liver metastases of neuroendocrine tumors (NET). Somatostatin receptor scintigraphy (Octreo-Scan, Mallinckrodt-Diagnostica, Petten, the Netherlands) is a method for localization and staging NET: The aim of our prospective study was to evaluate the effectiveness of somatostatin receptor scintigraphy in the identification of extrahepatic tumor spread. Methods. Thirty-five patients with liver metastases of NET were studied over a 5-year period. The presence of NET was confirmed histologically in all cases. To detect extrahepatic metastases or local tumor recurrence, conventional imaging techniques and somatostatin receptor scintigraphy were carried out. Results. In correlation with the findings of conventional imaging methods, somatostatin receptor scintigraphy confirmed liver metastases in all patients. Additionally, 19 of 35 patients (54.2 %) had extrahepatic: tumor lesions not detected by other imaging techniques. Of those, 15 had extensive abdominal or thoracic lymph node metastases, 3 patients had bone metastases, and in 1 patient with bronchial carcinoid local tumor recurrence was detected. All 19 patients were excluded from further evaluation for liver resection or transplantation and subjected to conservative treatment. The somatostatin receptor scintigraphy sensitivity, confirmed at the time of operation, was 91.6%. In I patient, in whom cluster transplantation was performed, somatostatin receptor scintigraphy failed to disclose disseminated carcinosis of the pleural cavity, detected at autopsy (false-negative rate 8.3 %). Conclusion. In our experience, somatostatin receptor scintigraphy provides a highly sensitive diagnostic method to localize metastases of NET: We recommend somatostatin receptor scintigraphy before liver surgery in every patient with hepatic metastases of NET to identify candidates suitable for resection.
引用
收藏
页码:1000 / 1004
页数:5
相关论文
共 19 条
  • [1] MOLECULAR-BIOLOGY OF SOMATOSTATIN RECEPTORS
    BELL, GI
    REISINE, T
    [J]. TRENDS IN NEUROSCIENCES, 1993, 16 (01) : 34 - 38
  • [2] Treatment of liver metastases in patients with neuroendocrine tumors
    Frilling, A
    Rogiers, X
    Malago, M
    Liedke, OM
    Kaun, M
    Broelsch, CE
    [J]. LANGENBECKS ARCHIVES OF SURGERY, 1998, 383 (01) : 62 - 70
  • [3] Somatostatin receptor scintigraphy: Its sensitivity compared with that of other imaging methods in detecting primary and metastatic gastrinomas - A prospective study
    Gibril, F
    Reynolds, JC
    Doppman, JL
    Chen, CC
    Venzon, DJ
    Termanini, B
    Weber, C
    Stewart, CA
    Jensen, RT
    [J]. ANNALS OF INTERNAL MEDICINE, 1996, 125 (01) : 26 - +
  • [4] Positive somatostatin receptor scintigraphy correlates with the presence of somatostatin receptor subtype 2
    John, M
    Meyerhof, W
    Richter, D
    Waser, B
    Schaer, JC
    Scherubl, H
    BoeseLandgraf, J
    Neuhaus, P
    Ziske, C
    Molling, K
    Riecken, EO
    Reubi, JC
    Wiedenmann, B
    [J]. GUT, 1996, 38 (01) : 33 - 39
  • [5] KRENNING EP, 1989, LANCET, V1, P242
  • [6] KRENNING EP, 1992, SCHWEIZ MED WSCHR, V122, P634
  • [7] IDENTIFICATION OF SOMATOSTATIN RECEPTOR SUBTYPES AND AN IMPLICATION FOR THE EFFICACY OF SOMATOSTATIN ANALOG SMS-201-995 IN TREATMENT OF HUMAN ENDOCRINE TUMORS
    KUBOTA, A
    YAMADA, Y
    KAGIMOTO, S
    SHIMATSU, A
    IMAMURA, M
    TSUDA, K
    IMURA, H
    SEINO, S
    SEINO, Y
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1994, 93 (03) : 1321 - 1325
  • [9] SOMATOSTATIN-RECEPTOR IMAGING IN THE LOCALIZATION OF ENDOCRINE TUMORS
    LAMBERTS, SWJ
    BAKKER, WH
    REUBI, JC
    KRENNING, EP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (18) : 1246 - 1249
  • [10] THE VISUALIZATION OF GASTROENTEROPANCREATIC ENDOCRINE TUMORS
    LAMBERTS, SWJ
    CHAYVIALLE, JA
    KRENNING, EP
    [J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (09): : 111 - 115